Alimera Sciences Inc. is a biopharmaceutical company that engaged in the research development and commercialization of ophthalmic pharmaceuticals.


Updates from The Motley Fool

Latest updates on Alimera Sciences from Fool.com.


Stock Performance

ALIM vs. S&P 500 | 2 Year Performance
View Interactive ALIM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alimera Sciences.
Current Price: $2.05
Prev Close: $2.07
Open: $2.00
Bid: $1.98
Ask: $2.06
Day's Range: $1.85 - $2.12
52wk Range: $1.02 - $5.15
Volume: 3,187,948
Avg Vol 1,165,617
Market Cap: $91.32M
P/E (ttm): -2.88
EPS (ttm): -$0.72
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alimera Sciences.
CAPS Rating 1 out of 5
 
62 Outperform
16 Underperform
CAPS All Stars
 
6 Outperform
7 Underperform

How do you think Alimera Sciences will perform against the market?



You pick for Alimera Sciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

C. Daniel Myers, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alimera Sciences.

Alimera Sciences Inc. is a biopharmaceutical company that engaged in the research development and commercialization of ophthalmic pharmaceuticals.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers